| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.3 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.3 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.3 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |